{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:01:10Z","timestamp":1794916870289,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T00:00:00Z","timestamp":1398211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T00:00:00Z","timestamp":1398211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>We investigated the clinical and serological features of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in Japan using data from a nationwide, prospective, inception cohort study.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>In total, 156 Japanese patients with newly diagnosed AAV were classified according to the European Medicines Agency (EMEA) algorithm with exploratory surrogate markers for AAV-related non-granulomatous pulmonary lesions, predefined as alveolar haemorrhage and interstitial lung disease (ILD), and their clinical and serological features were evaluated.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Using the EMEA algorithm, we identified 14 patients (9.0%) with eosinophilic granulomatosis with polyangiitis (EGPA), 33 (21.2%) with granulomatosis with polyangiitis (GPA), 78 (50.0%) with microscopic polyangiitis and renal-limited vasculitis (MPA\/RLV), and 31 (19.9%) with unclassifiable vasculitis. The average ages of patients with EGPA (male\/female, 5\/9), GPA (12\/21), and MPA\/RLV (35\/43) and unclassifiable (9\/22) were 58.0, 63.6, 71.1, and 70.6\u00a0years, respectively. Myeloperoxidase (MPO)-ANCA and proteinase-3 ANCA positivity was 50.0% and 0% for EGPA, 54.6% and 45.5% for GPA, 97.4% and 2.6% for MPA\/RLV, and 93.5% and 3.2% for unclassifiable, respectively. According to the Birmingham Vasculitis Activity Score (BVAS), cutaneous (71.4%) and nervous system (92.9%) manifestations were prominent in EGPA and ear, nose, and throat manifestations (84.9%) and chest manifestations (66.7%) in GPA. Renal manifestations developed frequently in MPA\/RLV (91.0%) and GPA (63.6%). The average serum creatinine levels were 0.71\u00a0mg\/dL for EGPA, 1.51\u00a0mg\/dL for GPA, 2.46\u00a0mg\/dL for MPA\/RLV, and 0.69\u00a0mg\/dL for unclassifiable. The percentages of patients with ILD were 14.3% for EGPA, 9.0% for GPA, 47.4% for MPA\/RLV, and 61.3% for unclassifiable. Patients with ILD (<jats:italic>n<\/jats:italic>\u2009=\u200961) had significantly lower BVAS (<jats:italic>P<\/jats:italic>\u2009=\u20090.019) with fewer ear, nose, and throat and cardiovascular manifestations than patients without ILD (<jats:italic>n<\/jats:italic>\u2009=\u200995).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>MPO-ANCA-positive MPA\/RLV is the most common form of AAV in Japanese patients, and one-half of patients with GPA were positive for MPO-ANCA. ILD is an important clinical manifestation in Japanese patients with AAV. Unclassifiable vasculitis with MPO-ANCA positivity and ILD may represent a novel variant of MPA.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Trial Registration<\/jats:title>\n                        <jats:p>The University Hospital Medical Information Network Clinical Trials Registry: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/upload.umin.ac.jp\/cgi-open-bin\/ctr\/ctr.cgi?function=brows&amp;action=brows&amp;type=summary&amp;recptno=R000001956&amp;language=E\">UMIN000001648<\/jats:ext-link>. Registered 28 February 2009.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar4550","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T09:11:29Z","timestamp":1398244289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":192,"title":["Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study"],"prefix":"10.1186","volume":"16","author":[{"given":"Ken-ei","family":"Sada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Harigai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Dobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinari","family":"Takasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Hirahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Arimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,23]]},"reference":[{"key":"4187_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"J Jennette","year":"2013","unstructured":"Jennette J, Falk R, Bacon P, Basu N, Cid M, Ferrario F, Flores-Suarez L, Gross W, Guillevin L, Hagen E, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA: Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013, 65: 1-11.","journal-title":"Arthritis Rheum"},{"key":"4187_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jennette","year":"1994","unstructured":"Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, McCluskey RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994, 37: 187-192. 10.1002\/art.1780370206.","journal-title":"Arthritis Rheum"},{"key":"4187_CR3","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1093\/rheumatology\/ker205","volume":"50","author":"S Fujimoto","year":"2011","unstructured":"Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DR, Scott DG, Hashimoto H, Nunoi H: Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology (Oxford). 2011, 50: 1916-1920. 10.1093\/rheumatology\/ker205.","journal-title":"Rheumatology (Oxford)"},{"key":"4187_CR4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/ard.2006.054593","volume":"66","author":"R Watts","year":"2007","unstructured":"Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen-Tervaert JW, Scott D: Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007, 66: 222-227.","journal-title":"Ann Rheum Dis"},{"key":"4187_CR5","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/rheumatology\/ken079","volume":"47","author":"LJ Liu","year":"2008","unstructured":"Liu LJ, Chen M, Yu F, Zhao MH, Wang HY: Evaluation of a new algorithm in classification of systemic vasculitis. Rheumatology (Oxford). 2008, 47: 708-712. 10.1093\/rheumatology\/ken079.","journal-title":"Rheumatology (Oxford)"},{"key":"4187_CR6","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/rheumatology\/ker454","volume":"51","author":"RA Watts","year":"2012","unstructured":"Watts RA, Mooney J, Skinner J, Scott DG, Macgregor AJ: The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis. Rheumatology (Oxford). 2012, 51: 926-931. 10.1093\/rheumatology\/ker454.","journal-title":"Rheumatology (Oxford)"},{"key":"4187_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2215\/CJN.07300712","volume":"8","author":"R Goupil","year":"2013","unstructured":"Goupil R, Brachemi S, Nadeau-Fredette AC, Deziel C, Troyanov Y, Lavergne V, Troyanov S: Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis. Clin J Am Soc Nephrol. 2013, 8: 416-423. 10.2215\/CJN.07300712.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4187_CR8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3109\/s10165-011-0525-5","volume":"22","author":"S Ozaki","year":"2012","unstructured":"Ozaki S, Atsumi T, Hayashi T, Ishizu A, Kobayashi S, Kumagai S, Kurihara Y, Kurokawa MS, Makino H, Nagafuchi H, Nakabayashi K, Nishimoto N, Suka M, Tomino Y, Yamada H, Yamagata K, Yoshida M, Yumura W, Amano K, Arimura Y, Hatta K, Ito S, Kikuchi H, Muso E, Nakashima H, Ohsone Y, Suzuki Y, Hashimoto H, Koyama A, Matsuo S: Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study. Mod Rheumatol. 2012, 22: 394-404. 10.3109\/s10165-011-0525-5.","journal-title":"Mod Rheumatol"},{"key":"4187_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/MD.0b013e31817c744b","volume":"87","author":"M Chen","year":"2008","unstructured":"Chen M, Yu F, Zhang Y, Zhao MH: Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients. Medicine (Baltimore). 2008, 87: 203-209. 10.1097\/MD.0b013e31817c744b.","journal-title":"Medicine (Baltimore)"},{"key":"4187_CR10","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1007\/s00296-011-2079-4","volume":"32","author":"JK Ahn","year":"2012","unstructured":"Ahn JK, Hwang JW, Lee J, Jeon CH, Cha HS, Koh EM: Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea. Rheumatol Int. 2012, 32: 2979-2986. 10.1007\/s00296-011-2079-4.","journal-title":"Rheumatol Int"},{"key":"4187_CR11","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1093\/rheumatology\/ker236","volume":"50","author":"N Arulkumaran","year":"2011","unstructured":"Arulkumaran N, Periselneris N, Gaskin G, Strickland N, Ind PW, Pusey CD, Salama AD: Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford). 2011, 50: 2035-2043. 10.1093\/rheumatology\/ker236.","journal-title":"Rheumatology (Oxford)"},{"key":"4187_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/ndtplus\/sfq050","volume":"3","author":"A Bhanji","year":"2010","unstructured":"Bhanji A, Karim M: Pulmonary fibrosis-an uncommon manifestation of anti-myeloperoxidase-positive systemic vasculitis?. NDT Plus. 2010, 3: 351-353. 10.1093\/ndtplus\/sfq050.","journal-title":"NDT Plus"},{"key":"4187_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1440-1843.2004.00581.x","volume":"9","author":"S Homma","year":"2004","unstructured":"Homma S, Matsushita H, Nakata K: Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology. 2004, 9: 190-196. 10.1111\/j.1440-1843.2004.00581.x.","journal-title":"Respirology"},{"key":"4187_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982, 5: 649-655. 10.1097\/00000421-198212000-00014.","journal-title":"Am J Clin Oncol"},{"key":"4187_CR15","first-page":"671","volume":"87","author":"RA Luqmani","year":"1994","unstructured":"Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D: Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994, 87: 671-678.","journal-title":"QJM"},{"key":"4187_CR16","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/ard.2006.062711","volume":"66","author":"B Hellmich","year":"2007","unstructured":"Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott DG, Witter J, Yazici H, Luqmani RA: EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 2007, 66: 605-617. 10.1136\/ard.2006.062711.","journal-title":"Ann Rheum Dis"},{"key":"4187_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","volume":"90","author":"L Guillevin","year":"2011","unstructured":"Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P: The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore). 2011, 90: 19-27. 10.1097\/MD.0b013e318205a4c6.","journal-title":"Medicine (Baltimore)"},{"key":"4187_CR18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0","volume":"43","author":"RA Watts","year":"2000","unstructured":"Watts RA, Lane SE, Bentham G, Scott DG: Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum. 2000, 43: 414-419. 10.1002\/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0.","journal-title":"Arthritis Rheum"},{"key":"4187_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2215\/CJN.05610611","volume":"7","author":"JG McGregor","year":"2012","unstructured":"McGregor JG, Hogan SL, Hu Y, Jennette CE, Falk RJ, Nachman PH: Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease. Clin J Am Soc Nephrol. 2012, 7: 240-247. 10.2215\/CJN.05610611.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4187_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/ard.60.2.170","volume":"60","author":"RA Watts","year":"2001","unstructured":"Watts RA, Gonzalez-Gay MA, Lane SE, Garcia-Porrua C, Bentham G, Scott DG: Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis. 2001, 60: 170-172. 10.1136\/ard.60.2.170.","journal-title":"Ann Rheum Dis"},{"key":"4187_CR21","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/ard.60.12.1156a","volume":"60","author":"RA Watts","year":"2001","unstructured":"Watts RA, Lane SE, Scott DG, Koldingsnes W, Nossent H, Gonzalez-Gay MA, Garcia-Porrua C, Bentham GA: Epidemiology of vasculitis in Europe. Ann Rheum Dis. 2001, 60: 1156-1157. 10.1136\/ard.60.12.1156.","journal-title":"Ann Rheum Dis"},{"key":"4187_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/rheumatology\/kei259","volume":"45","author":"A Gibson","year":"2006","unstructured":"Gibson A, Stamp LK, Chapman PT, O'Donnell JL: The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology (Oxford). 2006, 45: 624-628. 10.1093\/rheumatology\/kei259.","journal-title":"Rheumatology (Oxford)"},{"key":"4187_CR23","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/annrheumdis-2012-201750","volume":"72","author":"A Mahr","year":"2013","unstructured":"Mahr A, Katsahian S, Varet H, Guillevin L, Hagen EC, Hoglund P, Merkel PA, Pagnoux C, Rasmussen N, Westman K, Jayne DR, French Vasculitis Study Group (FVSG); European Vasculitis Society (EUVAS): Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis. Ann Rheum Dis. 2013, 72: 1003-1010. 10.1136\/annrheumdis-2012-201750.","journal-title":"Ann Rheum Dis"},{"key":"4187_CR24","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/art.33361","volume":"64","author":"M Walsh","year":"2012","unstructured":"Walsh M, Flossmann O, Berden A, Westman K, Hoglund P, Stegeman C, Jayne D: Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2012, 64: 542-548. 10.1002\/art.33361.","journal-title":"Arthritis Rheum"},{"key":"4187_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1056\/NEJMoa1108735","volume":"367","author":"PA Lyons","year":"2012","unstructured":"Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen Tervaert JW, Deloukas P, Feighery C, Gross WL, Guillevin L, Gunnarsson I, Harper L, Hru\u0161kov\u00e1 Z, Little MA, Martorana D, Neumann T, Ohlsson S, Padmanabhan S, Pusey CD, Salama AD, Sanders JS, Savage CO, Segelmark M, Stegeman CA, Tesa\u0159 V: Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012, 367: 214-223. 10.1056\/NEJMoa1108735.","journal-title":"N Engl J Med"},{"key":"4187_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1046\/j.1523-1755.2002.00089.x","volume":"61","author":"HA Hauer","year":"2002","unstructured":"Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noel LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC: Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 2002, 61: 80-89. 10.1046\/j.1523-1755.2002.00089.x.","journal-title":"Kidney Int"},{"key":"4187_CR27","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.rmed.2008.04.023","volume":"102","author":"G Foulon","year":"2008","unstructured":"Foulon G, Delaval P, Valeyre D, Wallaert B, Debray MP, Brauner M, Nicaise P, Cadranel J, Cottin V, Tazi A, Aubier M, Crestani B: ANCA-associated lung fibrosis: analysis of 17 patients. Respir Med. 2008, 102: 1392-1398. 10.1016\/j.rmed.2008.04.023.","journal-title":"Respir Med"},{"key":"4187_CR28","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/ard.2008.096131","volume":"68","author":"B Hervier","year":"2009","unstructured":"Hervier B, Pagnoux C, Agard C, Haroche J, Amoura Z, Guillevin L, Hamidou MA: Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature. Ann Rheum Dis. 2009, 68: 404-407. 10.1136\/ard.2008.096131.","journal-title":"Ann Rheum Dis"},{"key":"4187_CR29","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.rmed.2013.01.006","volume":"107","author":"M Ando","year":"2013","unstructured":"Ando M, Miyazaki E, Ishii T, Mukai Y, Yamasue M, Fujisaki H, Ito T, Nureki S, Kumamoto T: Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis. Respir Med. 2013, 107: 608-615. 10.1016\/j.rmed.2013.01.006.","journal-title":"Respir Med"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar4550\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar4550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:14:48Z","timestamp":1728382488000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar4550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,23]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,4]]}},"alternative-id":["4187"],"URL":"https:\/\/doi.org\/10.1186\/ar4550","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,23]]},"assertion":[{"value":"16 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R101"}}